newsfilter
← Latest News
GlobeNewswire·

Eterna Therapeutics Hosts Successful Inaugural Meeting with Newly Formed Scientific Advisory Board to Advance Cell Therapy Pipeline

CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune diseases, today announced a